Studio Dragon eyes IPO as TissueGene closes
Studio Dragon has filed terms for its IPO in South Korea, with the “hallyu” company looking to raise W210bn ($186m).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: